Show simple item record

dc.contributor.authorRunzer-Colmenares, F.M.
dc.contributor.authorUrrunaga-Pastor, D.
dc.contributor.authorRoca-Moscoso, M.A.
dc.contributor.authorde Noriega, J.
dc.contributor.authorRosas-Carrasco, O.
dc.contributor.authorParodi, J.F.
dc.date.accessioned2025-10-31T18:36:02Z
dc.date.available2025-10-31T18:36:02Z
dc.date.issued2020
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5362
dc.description.abstractBackground: Multiple markers are used to assess frailty and vulnerability, conditions associated with the development of chemotherapy toxicity (CTT). However, there is still no consensus on which condition has stronger association with this adverse effect of chemotherapy in the elderly. Objectives: To evaluate the association between frailty and vulnerability with the development of CTT in oncogeriatric patients. Design, Setting, and Participants: Through a retrospective cohort, a secondary database of 496 male oncogeriatric military patients treated at the Geriatrics Service of the Naval Medical Centre of Peru during 2013–2015 was analyzed. Measurements: With prior informed consent, the presence of frailty, assessed by Fried Phenotype; and vulnerability, assessed by the Vulnerable Elders Survey-13 (VES-13) and G-8, was determined. The follow-up of patients in chemotherapy was performed every 8 weeks, to determine the development of CTT (according to the Common Terminology Criteria for Adverse Events v4.0). In addition, we included sociodemographic characteristics, medical background information and functional assessment variables. The data collected was encoded and imported into STATA v14.0 statistical package for analysis. Multivariate analysis was performed using crude and adjusted Cox regression models. The reported measure was the hazard ratio (HR) with their respective 95% confidence intervals (95%CI). Results: The average age was 79.2 ± 4.3 years. 129 (26.01%) developed CTT during follow-up. Similarly, 129 older adults (26.01%) were positive for frailty according to Fried phenotype; 101 (20.36%) were positive for vulnerability with VES-13, and 112 (22.58%) with G-8. In the adjusted Cox model, by type of cancer and adverse effects, a statistically significant association was found between the 3 scales evaluated and the development of CTT, with the Fried Phenotype as the scale with the strongest association (HR=2.01; 95%CI: 1.04–4.90). Conclusions: The frailty and vulnerability in the elderly are conditions associated with the development of CTT. The Fried phenotype was the scale with the most significant association with the outcome studied.en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherSerdi-Editions
dc.relation.ispartofurn:issn:1760-4788
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectOvarian Cancer Management and Patient Outcomesen_US
dc.subjectGeriatric Assessment in Cancer Treatment Optimizationen_US
dc.titleFrailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peruen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1007/s12603-020-1404-6
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#1.02.02
dc.type.otherResearch article
dc.identifier.journalJournal of Nutrition, Health and Aging
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2